These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 35905785)
21. Rhamnolipids form drug-loaded nanoparticles for dermal drug delivery. Müller F; Hönzke S; Luthardt WO; Wong EL; Unbehauen M; Bauer J; Haag R; Hedtrich S; Rühl E; Rademann J Eur J Pharm Biopharm; 2017 Jul; 116():31-37. PubMed ID: 28012989 [TBL] [Abstract][Full Text] [Related]
22. Comparative assessment of efficacy and safety potential of multifarious lipid based Tacrolimus loaded nanoformulations. Jain S; Addan R; Kushwah V; Harde H; Mahajan RR Int J Pharm; 2019 May; 562():96-104. PubMed ID: 30902706 [TBL] [Abstract][Full Text] [Related]
23. Development and evaluation of colloidal modified nanolipid carrier: application to topical delivery of tacrolimus, Part II--in vivo assessment, drug targeting, efficacy, and safety in treatment for atopic dermatitis. Pople PV; Singh KK Eur J Pharm Biopharm; 2013 May; 84(1):72-83. PubMed ID: 23246619 [TBL] [Abstract][Full Text] [Related]
24. Influence of nanocarrier type and size on skin delivery of hydrophilic agents. Küchler S; Abdel-Mottaleb M; Lamprecht A; Radowski MR; Haag R; Schäfer-Korting M Int J Pharm; 2009 Jul; 377(1-2):169-72. PubMed ID: 19439166 [TBL] [Abstract][Full Text] [Related]
25. Integrating tacrolimus into eutectic oil-based microemulsion for atopic dermatitis: simultaneously enhancing percutaneous delivery and treatment efficacy with relieving side effects. Wang Y; Cao S; Yu K; Yang F; Yu X; Zhai Y; Wu C; Xu Y Int J Nanomedicine; 2019; 14():5849-5863. PubMed ID: 31440050 [No Abstract] [Full Text] [Related]
26. Development and evaluation of colloidal modified nanolipid carrier: application to topical delivery of tacrolimus. Pople PV; Singh KK Eur J Pharm Biopharm; 2011 Sep; 79(1):82-94. PubMed ID: 21447390 [TBL] [Abstract][Full Text] [Related]
27. Tacrolimus ointment. A review of its therapeutic potential as a topical therapy in atopic dermatitis. Cheer SM; Plosker GL Am J Clin Dermatol; 2001; 2(6):389-406. PubMed ID: 11770393 [TBL] [Abstract][Full Text] [Related]
28. Dermal targeting of tacrolimus using colloidal carrier systems. Goebel AS; Neubert RH; Wohlrab J Int J Pharm; 2011 Feb; 404(1-2):159-68. PubMed ID: 21094231 [TBL] [Abstract][Full Text] [Related]
29. Dermal peptide delivery using enhancer moleculs and colloidal carrier systems. Part II: Tetrapeptide PKEK. Neubert RHH; Sommer E; Schölzel M; Tuchscherer B; Mrestani Y; Wohlrab J Eur J Pharm Biopharm; 2018 Mar; 124():28-33. PubMed ID: 29247690 [TBL] [Abstract][Full Text] [Related]
30. Penetration of normal, damaged and diseased skin--an in vitro study on dendritic core-multishell nanotransporters. Alnasif N; Zoschke C; Fleige E; Brodwolf R; Boreham A; Rühl E; Eckl KM; Merk HF; Hennies HC; Alexiev U; Haag R; Küchler S; Schäfer-Korting M J Control Release; 2014 Jul; 185():45-50. PubMed ID: 24727058 [TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo trans-epidermal water loss evaluation following topical drug delivery systems application for pharmaceutical analysis. Cristiano MC; Froiio F; Mancuso A; Iannone M; Fresta M; Fiorito S; Celia C; Paolino D J Pharm Biomed Anal; 2020 Jul; 186():113295. PubMed ID: 32361608 [TBL] [Abstract][Full Text] [Related]
32. Ethyl cellulose nanocarriers and nanocrystals differentially deliver dexamethasone into intact, tape-stripped or sodium lauryl sulfate-exposed ex vivo human skin - assessment by intradermal microdialysis and extraction from the different skin layers. Döge N; Hönzke S; Schumacher F; Balzus B; Colombo M; Hadam S; Rancan F; Blume-Peytavi U; Schäfer-Korting M; Schindler A; Rühl E; Skov PS; Church MK; Hedtrich S; Kleuser B; Bodmeier R; Vogt A J Control Release; 2016 Nov; 242():25-34. PubMed ID: 27394682 [TBL] [Abstract][Full Text] [Related]
33. Tacrolimus nanoparticles based on chitosan combined with nicotinamide: enhancing percutaneous delivery and treatment efficacy for atopic dermatitis and reducing dose. Yu K; Wang Y; Wan T; Zhai Y; Cao S; Ruan W; Wu C; Xu Y Int J Nanomedicine; 2018; 13():129-142. PubMed ID: 29317821 [TBL] [Abstract][Full Text] [Related]
34. Improved tacrolimus skin permeation by co-encapsulation with clobetasol in lipid nanoparticles: Study of drug effects in lipid matrix by electron paramagnetic resonance. Andrade LM; Silva LAD; Krawczyk-Santos AP; Amorim ICSM; Rocha PBRD; Lima EM; Anjos JLV; Alonso A; Marreto RN; Taveira SF Eur J Pharm Biopharm; 2017 Oct; 119():142-149. PubMed ID: 28627400 [TBL] [Abstract][Full Text] [Related]
35. [Pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adult and paediatric patients with atopic dermatitis]. Undre NA Actas Dermosifiliogr; 2008 Feb; 99 Suppl 2():2-7. PubMed ID: 18346423 [TBL] [Abstract][Full Text] [Related]
36. The role of stratum corneum and dermal microvascular perfusion in penetration and tissue levels of water-soluble drugs investigated by microdialysis. Morgan CJ; Renwick AG; Friedmann PS Br J Dermatol; 2003 Mar; 148(3):434-43. PubMed ID: 12653734 [TBL] [Abstract][Full Text] [Related]
37. Investigation of cutaneous penetration properties of stearic acid loaded to dendritic core-multi-shell (CMS) nanocarriers. Lohan SB; Icken N; Teutloff C; Saeidpour S; Bittl R; Lademann J; Fleige E; Haag R; Haag SF; Meinke MC Int J Pharm; 2016 Mar; 501(1-2):271-7. PubMed ID: 26853315 [TBL] [Abstract][Full Text] [Related]
38. Tacrolimus nanocrystals microneedle patch for plaque psoriasis. Men Z; Su T; Tang Z; Liang J; Shen T Int J Pharm; 2022 Nov; 627():122207. PubMed ID: 36122614 [TBL] [Abstract][Full Text] [Related]
39. Recent Approaches on Novel Topical Delivery Systems for Atopic Dermatitis Treatment. Kahraman E; Aydilek N; Güngör S Recent Pat Drug Deliv Formul; 2020; 14(3):191-200. PubMed ID: 32819264 [TBL] [Abstract][Full Text] [Related]
40. Colloidal nanocarriers for the enhanced cutaneous delivery of naftifine: characterization studies and in vitro and in vivo evaluations. Erdal MS; Özhan G; Mat MC; Özsoy Y; Güngör S Int J Nanomedicine; 2016; 11():1027-37. PubMed ID: 27042058 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]